XML 44 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings Per Common Share (Tables)
 6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Earnings per Share
The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2020
 
2019
 
2020
 
2019
Numerator
 
 
 
 
 
 
 
Net income (loss)
$
55,049

 
$
(9,980
)
 
$
337,589

 
$
55,010

Noncontrolling interests' share in earnings
(3,543
)
 
(3,617
)
 
(7,003
)
 
(7,137
)
Net income (loss) attributable to Healthpeak Properties, Inc.
51,506

 
(13,597
)
 
330,586

 
47,873

Less: Participating securities' share in earnings
(375
)
 
(394
)
 
(1,800
)
 
(837
)
Net income (loss) applicable to common shares
$
51,131

 
$
(13,991
)
 
$
328,786

 
$
47,036

Denominator
 

 
 

 
 
 
 
Basic weighted average shares outstanding
538,262

 
478,739

 
522,427

 
478,260

Dilutive potential common shares - equity awards(1)
255

 
—

 
263

 
281

Dilutive potential common shares - forward equity agreements(2)
—

 
—

 
808

 
1,344

Diluted weighted average common shares
538,517

 
478,739

 
523,498

 
479,885

Earnings (loss) per common share:
 
 
 
 
 
 
 
Basic
$
0.09

 
$
(0.03
)
 
$
0.63

 
$
0.10

Diluted
$
0.09

 
$
(0.03
)
 
$
0.63

 
$
0.10


_______________________________________
(1)
For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options).
(2)
For the six months ended June 30, 2020, represents the dilutive impact of 32 million shares that were settled during the six months then ended. For the six months ended June 30, 2019, represents the dilutive impact of 7 million shares that were settled during the six months then ended and 22 million shares of common stock under forward sales agreements that had not been settled as of June 30, 2019. For the three months ended June 30, 2020, forward sales agreements had no dilutive impact as all agreements were settled prior to the start of the period. For the three months ended June 30, 2019, diluted loss per share is calculated using the weighted average common shares outstanding as a result of the Company generating a net loss applicable to common shares for the period.